Research has shown that Black patients are less likely to be diagnosed with bipolar disorder as opposed to schizophrenia, and a study published in 2023 found that Black patients with bipolar disorder ...

Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy ...

The first under-the-skin, long-acting risperidone injection offers a new maintenance option for adults with bipolar 1 disorder. For anyone managing bipolar 1 disorder, staying consistent with daily ...

The biopharmaceutical company said Friday Bysanti tablets were approved for the acute treatment of manic or mixed episodes associated with bipolar I disorder, as well as for the treatment of ...

The University of Texas Dell Medical School has joined a global study of bipolar type 1 disorder to better understand which treatments work and to identify biomarkers connected to manic or depressive ...

Valerie Taylor's research explores links between gut bacteria and bipolar disorder, testing faecal microbiota transplants as potential treatments for mental illness.

According to Mental Health America, bipolar disorder affects an estimated 4.4% of the United States population. Black ...

Around 40 million people around the world have bipolar disorder, which involves cyclical swings between moods: from depression to mania. Kay Redfield Jamison is one of those people. She's also a ...

Please provide your email address to receive an email when new articles are posted on . Tesla Coil may offer therapeutic drug monitoring for those with certain neuropsychiatric conditions. Alzamend ...